The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.
about
Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisAdipose tissue and adipokines: the association with and application of adipokines in obesitySignal transductions and nonalcoholic fatty liver: a mini-reviewMolecular Pathogenesis of NASHSchisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver DiseaseNon-alcoholic fatty liver disease: need for a balanced nutritional sourceUpregulation of UCP2 by adiponectin: the involvement of mitochondrial superoxide and hnRNP KAggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in ratsAnti-Inflammatory Properties of Brazilian Green Propolis Encapsulated in a γ-Cyclodextrin Complex in Mice Fed a Western-Type Diet.Clodronate liposomes improve metabolic profile and reduce visceral adipose macrophage content in diet-induced obese miceLiver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance.Genetic determinants of hepatic steatosis in man.Salsalate and Adiponectin Improve Palmitate-Induced Insulin Resistance via Inhibition of Selenoprotein P through the AMPK-FOXO1α Pathway.Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver diseaseStem cell transplantation upregulates Sirt1 and antioxidant expression, ameliorating fatty liver in type 2 diabetic mice.Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease.ER Stress and Lipid Metabolism in Adipocytes.Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney DiseaseMultidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver.Non-alcoholic fatty liver disease and diabetes.Relationship between aspartate aminotransferase-to-platelet ratio index and carotid intima-media thickness in obese adolescents with non-alcoholic fatty liver disease.Pathophysiology of NASH: perspectives for a targeted treatment.Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease.The bone and fat connection in inflammatory bowel diseases.GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells.Caring for children with NAFLD and navigating their care into adulthood.Emerging and future therapies for nonalcoholic steatohepatitis in adults.Adiponectin promoter activator NP-1 reduces body weight and hepatic steatosis in high-fat diet-fed animals.Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection.Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targetsHigh protein/fish oil diet prevents hepatic steatosis in NONcNZO10 mice; association with diet/genetics-regulated micro-RNAsLiver fibrogenesis in non-alcoholic steatohepatitis.Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice.Synthesis and biological evaluation of novel urea- and guanidine-based derivatives for the treatment of obesity-related hepatic steatosis.Helicobacter pylori infection and serum adiponectin.Vps34 PI 3-kinase inactivation enhances insulin sensitivity through reprogramming of mitochondrial metabolism.A "healthy diet-optimal sleep" lifestyle pattern is inversely associated with liver stiffness and insulin resistance in patients with nonalcoholic fatty liver disease.Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.
P2860
Q26775340-8EC775A6-273A-45ED-B695-0D1BB60402F4Q26830052-2D99B67E-B125-43D7-9600-645A0BB6ABFAQ26991757-03014E5B-7DBD-45F4-A172-3B8E226E1ABEQ28071265-1DCF4753-13D3-49E2-8733-1854DE2151A3Q28078342-E4AF1BF3-278F-4BD7-BCD2-9557B357EFCFQ28248994-61DC694B-EB85-43CE-A767-7298BC1AF26AQ28480923-204A47F9-BF13-409F-A523-124FC23FCA6AQ28573665-6ACD1711-9639-4329-B688-B6A68D084C7DQ33838489-C850E32A-2EBF-4FCD-892D-8799EAB46441Q34023415-C3E51DB5-83F1-462C-B241-16C6D6B2066AQ34168368-4CF66BF0-2108-4F55-8D57-0427FA9CF4AAQ34646183-A86E787A-1E8D-4DA8-A2A9-937AFEBFF6C8Q34794081-1193D9DC-1006-48DA-93C4-85EB5F4EDC7EQ34971028-9F9E1E7F-AEFC-4349-8E72-C72394A961CEQ35197524-EEF64A90-B7C5-4573-9BF2-53C65C719EEFQ35753386-557A2B30-AC85-4319-BB4A-3C45C2EA0510Q35779442-8033A0B8-2FE5-4499-84B8-336A15EA21B1Q36095550-01269607-C89F-456D-9F72-1E7F00202A6EQ36470320-3FA0A887-556B-4B47-A0AB-696781B463A9Q36895945-C6CA6FFC-2D7D-4529-B582-C9802C432741Q37091659-B34E077D-8ACB-4ABB-90C6-894B83250EEEQ37270922-F15E3EDA-14BC-40E1-ADA4-29FC87C63458Q37699476-F1E5CBB8-1790-4E40-9CCC-A215ACDF332DQ38181562-330D4D65-151A-4CE4-9802-6419BF30EA19Q38188874-B6A5808D-E05E-465D-A09A-A8F5478E51AAQ38225220-F53A951B-480F-4B0B-BBF2-FFA9ED86FF87Q38303031-D6834B86-8261-4606-A12A-7B1DAC01778BQ38577570-357CC6B6-0DF5-484B-9B55-7BBE102D07D8Q38827586-1F245B88-B9A5-4C5A-A273-A228EF859E3EQ39403052-31528408-86E2-4947-9817-019F44EC7F3BQ41412291-26D1FBC9-838F-45C7-8ACD-51EFC44DAA33Q41694135-FDF3F547-20FD-43F7-B7AA-6A706B58AA9DQ41940630-A48D9EA2-80BF-4DB4-B47C-AB428B01AC5EQ42321514-5613EDA0-6828-4D51-8FE5-058F3FCD1E6FQ42744201-2BA41DE1-5F92-42B5-87D1-CEF8F659BE3BQ42802652-D338369F-FEC1-4811-AFA4-5CD5B98CAE4CQ44200468-260625EE-855C-47E7-8A0F-3953D3DC0DBEQ47148137-AF141212-39F4-4DAC-A550-3EDEB75E00F6Q47769655-1C884BBB-4A82-45A4-8DF7-61BFFCDBD4EAQ48220163-77EFC3F9-61CC-4C02-9382-55F79A0522B9
P2860
The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of adiponectin in the ...... alcoholic fatty liver disease.
@en
The role of adiponectin in the ...... alcoholic fatty liver disease.
@nl
type
label
The role of adiponectin in the ...... alcoholic fatty liver disease.
@en
The role of adiponectin in the ...... alcoholic fatty liver disease.
@nl
prefLabel
The role of adiponectin in the ...... alcoholic fatty liver disease.
@en
The role of adiponectin in the ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P1476
The role of adiponectin in the ...... alcoholic fatty liver disease.
@en
P2093
Christos Zavos
Eleni Tsiaousi
Jannis Kountouras
Stergios A Polyzos
P2860
P304
P356
10.1111/J.1463-1326.2009.01176.X
P577
2010-05-01T00:00:00Z